IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Nov 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-11-08

Reporting Person: MCKEON BRIAN P (Executive VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-08	Common Stock	M	10000	$67.85	Acquired	36316.6426	Direct
2021-11-08	Common Stock	S	1300	$625.2493	Disposed	35016.6426	Direct
2021-11-08	Common Stock	S	1100	$626.4747	Disposed	33916.6426	Direct
2021-11-08	Common Stock	S	1326	$627.4069	Disposed	32590.6426	Direct
2021-11-08	Common Stock	S	2356	$628.1935	Disposed	30234.6426	Direct
2021-11-08	Common Stock	S	2094	$629.6305	Disposed	28140.6426	Direct
2021-11-08	Common Stock	S	971	$630.3937	Disposed	27169.6426	Direct
2021-11-08	Common Stock	S	743	$631.3885	Disposed	26426.6426	Direct
2021-11-08	Common Stock	S	110	$632.1922	Disposed	26316.6426	Direct
2021-11-09	Common Stock	M	6310	$67.85	Acquired	32626.6426	Direct
2021-11-09	Common Stock	S	5703	$630.1337	Disposed	26923.6426	Direct
2021-11-09	Common Stock	S	607	$631.0108	Disposed	26316.6426	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-08	Non-Qualified Stock Option (right-to-buy)	$67.85	M	10000	Disposed	2026-02-13	Common Stock (10000)	Direct
2021-11-09	Non-Qualified Stock Option (right-to-buy)	$67.85	M	6310	Disposed	2026-02-13	Common Stock (6310)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18050	Indirect

Footnotes

F1: Includes 9 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021.

F2: This transaction was executed in multiple trades at prices ranging from $625.00 to $625.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $626.10 to $627.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $627.07 to $628.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $628.01 to $628.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $629.10 to $629.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $630.03 to $630.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: This transaction was executed in multiple trades at prices ranging from $631.10 to $631.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: This transaction was executed in multiple trades at prices ranging from $632.01 to $632.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F10: This transaction was executed in multiple trades at prices ranging from $630.00 to $631.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $631.005 to $631.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017.

F13: Not applicable.